Synaptic mechanisms regulating sympathetic drive

调节交感神经驱动的突触机制

基本信息

  • 批准号:
    8692568
  • 负责人:
  • 金额:
    $ 41.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The sympathetic drive emanating from the brain is increased in animal models of hypertension and in patients with primary hypertension. The paraventricular nucleus (PVN) of the hypothalamus is an important site for the control of sympathetic outflow through its projections to sympathetically related sites in the brainstem and spinal cord. During the previous funding period, we showed that augmented glutamatergic input contributes to increased excitability of PVN presympathetic neurons and elevated sympathetic vasomotor tone in the animal model of hypertension. However, little is known about the molecular mechanisms underlying the sustained increase in glutamatergic input to the PVN in hypertension. Our recent study suggests that group I metabotropic glutamate receptors (mGluRs) in the PVN are critically involved in the support of elevated sympathetic outflow in hypertension. In this competing renewal proposal, we will use spontaneously hypertensive rats and renovascular hypertensive rats as animal models of hypertension to test our central hypothesis that group I mGluRs are upregulated at presynaptic and postsynaptic sites, which leads to increased glutamatergic input and excitability of PVN presympathetic neurons in hypertension. Our specific aims are to determine (1) the changes in the expression and distribution of group I mGluRs in the PVN during the development of hypertension; (2) the contribution of presynaptic group I mGluRs to augmented glutamatergic synaptic input to PVN presympathetic neurons in hypertension; (3)the downstream mechanisms mediating increased excitability of PVN presympathetic neurons by activation of postsynaptic group I mGluRs in hypertension; and (4) the changes in calcineurin activity and their contribution to increased group I mGluR and NMDA channel activity in the PVN in hypertension. The important roles of group I mGluRs and calcineurin in increased glutamatergic input in the PVN have not been recognized previously. Our proposed studies are expected to unravel a cascade of molecular events responsible for the sustained increase in sympathetic vasomotor tone in hypertension. This new information should have a major impact on our understanding of the fundamental neurogenic mechanisms underlying the development of primary and secondary hypertension and on the design of new treatments for hypertension.
描述(由申请人提供):在高血压动物模型和原发性高血压患者中,从大脑发出的交感神经驱动力增加。下丘脑的室室核(PVN)是通过其对脑干和脊髓中交感相关部位的投影控制交感神经流出的重要部位。在上一个资金期间,我们表明,增强的谷氨酸能输入有助于PVN预感神经元的兴奋性增加,并且在高血压动物模型中升高了交感神经肌张力张力。然而,关于高血压中PVN持续增加的谷氨酸能输入持续增加的分子机制知之甚少。我们最近的研究表明,PVN中的I组代谢型谷氨酸受体(MGLURS)与高血压中的交感神经流升高有关。 In this competing renewal proposal, we will use spontaneously hypertensive rats and renovascular hypertensive rats as animal models of hypertension to test our central hypothesis that group I mGluRs are upregulated at presynaptic and postsynaptic sites, which leads to increased glutamatergic input and excitability of PVN presympathetic neurons in hypertension.我们的具体目的是确定(1)高血压发育过程中I组MGLURS组的表达和分布的变化; (2)突触前组MGLURS对高血压中PVN前交感神经元增强谷氨酸能突触输入的贡献; (3)通过在高血压中突触后I mGlurs激活PVN的同情神经元兴奋性提高的下游机制; (4)高血压中PVN中PVN中钙调神经酶活性的变化及其对增加的I组和NMDA通道活性的贡献。先前尚未识别出PVN中I组MGLURS和钙调蛋白在增加的谷氨酸能输入中的重要作用。我们提出的研究预计将揭示一系列级联的分子事件,导致高血压中交感神经舒张肌张力的持续增加。这些新信息应该对我们对原发性和继发性高血压发展的基本神经源性机制以及对高血压新治疗的设计产生重大影响。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protein kinase CK2 contributes to diminished small conductance Ca2+-activated K+ channel activity of hypothalamic pre-sympathetic neurons in hypertension.
  • DOI:
    10.1111/jnc.12758
  • 发表时间:
    2014-09
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Pachuau J;Li DP;Chen SR;Lee HA;Pan HL
  • 通讯作者:
    Pan HL
NKCC1 upregulation disrupts chloride homeostasis in the hypothalamus and increases neuronal activity-sympathetic drive in hypertension.
Regulation of Hypothalamic Presympathetic Neurons and Sympathetic Outflow by Group II Metabotropic Glutamate Receptors in Spontaneously Hypertensive Rats.
Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hui-Lin Pan其他文献

Hui-Lin Pan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hui-Lin Pan', 18)}}的其他基金

Neural Mechanisms of Calcineurin Inhibitor-Induced Hypertension
钙调神经磷酸酶抑制剂诱发高血压的神经机制
  • 批准号:
    10669034
  • 财政年份:
    2020
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neural Mechanisms of Calcineurin Inhibitor-Induced Hypertension
钙调神经磷酸酶抑制剂诱发高血压的神经机制
  • 批准号:
    10457895
  • 财政年份:
    2020
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neural Mechanisms of Calcineurin Inhibitor-Induced Hypertension
钙调神经磷酸酶抑制剂诱发高血压的神经机制
  • 批准号:
    10224340
  • 财政年份:
    2020
  • 资助金额:
    $ 41.6万
  • 项目类别:
Signaling Mechanisms of Opioid-Induced Hyperalgesia and Tolerance
阿片类药物引起的痛觉过敏和耐受性的信号机制
  • 批准号:
    9251088
  • 财政年份:
    2017
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neuronal Plasticity and Signaling in Neuropathic Pain
神经病理性疼痛中的神经元可塑性和信号传导
  • 批准号:
    8021606
  • 财政年份:
    2011
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neuronal Plasticity and Signaling in Neuropathic Pain
神经病理性疼痛中的神经元可塑性和信号传导
  • 批准号:
    8241913
  • 财政年份:
    2011
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neuronal Plasticity and Signaling in Neuropathic Pain
神经病理性疼痛中的神经元可塑性和信号传导
  • 批准号:
    8640990
  • 财政年份:
    2011
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neuronal Plasticity and Signaling in Neuropathic Pain
神经病理性疼痛中的神经元可塑性和信号传导
  • 批准号:
    8443851
  • 财政年份:
    2011
  • 资助金额:
    $ 41.6万
  • 项目类别:
Neuronal Plasticity and Signaling in Neuropathic Pain
神经病理性疼痛中的神经元可塑性和信号传导
  • 批准号:
    8839310
  • 财政年份:
    2011
  • 资助金额:
    $ 41.6万
  • 项目类别:
Synaptic Mechanisms Regulating Sympathetic Drive
调节交感神经驱动的突触机制
  • 批准号:
    7056798
  • 财政年份:
    2005
  • 资助金额:
    $ 41.6万
  • 项目类别:

相似国自然基金

不同生态类型的海洋桡足类对硅藻的利用与适应的生态遗传学研究
  • 批准号:
    41276132
  • 批准年份:
    2012
  • 资助金额:
    78.0 万元
  • 项目类别:
    面上项目
有色棉特异种质的生物学及利用研究
  • 批准号:
    30370858
  • 批准年份:
    2003
  • 资助金额:
    18.0 万元
  • 项目类别:
    面上项目
青海高原珍稀兽类的细胞遗传学和生化遗传学研究
  • 批准号:
    39460057
  • 批准年份:
    1994
  • 资助金额:
    6.5 万元
  • 项目类别:
    地区科学基金项目
柞蚕幼虫体色的生化遗传学研究
  • 批准号:
    39470548
  • 批准年份:
    1994
  • 资助金额:
    6.0 万元
  • 项目类别:
    面上项目

相似海外基金

Cellular mechanism of Arid1b haploinsufficiency-associated social deficit
Arid1b单倍体不足相关的社会缺陷的细胞机制
  • 批准号:
    10736386
  • 财政年份:
    2023
  • 资助金额:
    $ 41.6万
  • 项目类别:
ShEEP Request for A Namocell PALA Single CellDispenser
ShEEP 请求 Namocell PALA 单细胞分配器
  • 批准号:
    10739131
  • 财政年份:
    2023
  • 资助金额:
    $ 41.6万
  • 项目类别:
Microglia dysregulation and SYK signaling in Alzheimer's disease
阿尔茨海默病中的小胶质细胞失调和 SYK 信号传导
  • 批准号:
    10659670
  • 财政年份:
    2023
  • 资助金额:
    $ 41.6万
  • 项目类别:
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease
USP30 抑制剂在帕金森病相关模型中的体内评价
  • 批准号:
    10603217
  • 财政年份:
    2023
  • 资助金额:
    $ 41.6万
  • 项目类别:
Antibiotic tolerance: membraneless organelles and autolysin regulation
抗生素耐受:无膜细胞器和自溶素调节
  • 批准号:
    10333641
  • 财政年份:
    2022
  • 资助金额:
    $ 41.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了